{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:29:57Z","timestamp":1769689797143,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jocn.2014.10.022","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T14:18:47Z","timestamp":1423491527000},"page":"632-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Treatment of leptomeningeal carcinomatosis: Current challenges and future opportunities"],"prefix":"10.1016","volume":"22","author":[{"given":"Manisha","family":"Kak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika E.","family":"Ramsdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimas V.","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.10.022_b0005","unstructured":"Surveillance, Epidemiology, and End Results Program: Turning Cancer Data into Discovery. Page on SEER Stat Fact Sheets: Breast Cancer. Available from: http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html [accessed on Aug 24, 2014]."},{"key":"10.1016\/j.jocn.2014.10.022_b0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0733-8619(02)00032-4","article-title":"Leptomeningeal metastases","volume":"21","author":"Kesari","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jocn.2014.10.022_b0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","article-title":"Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment","volume":"67","author":"Boogerd","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jso.2930230311","article-title":"Breast carcinoma: pattern of metastasis at autopsy","volume":"23","author":"Lee","year":"1983","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2012.10.009","article-title":"Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis","volume":"22","author":"Torrej\u00f3n","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.jocn.2014.10.022_b0045","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8","article-title":"Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant","volume":"74","author":"Jayson","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis\u2013the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and outcome","volume":"104","author":"de Azevedo","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0065","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.49.11.1246","article-title":"Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer","volume":"49","author":"Twijnstra","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2014.10.022_b0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.410080609","article-title":"Cerebrospinal fluid biochemical markers of central nervous system metastases","volume":"8","author":"Schold","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.10.022_b0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-009-9819-2","article-title":"Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma","volume":"94","author":"Groves","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-014-1361-1","article-title":"CSF CA 15\u20133 in breast cancer-related leptomeningeal metastases","volume":"117","author":"Le Rhun","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0085","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the MRI era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.10.022_b0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005783507544","article-title":"Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging","volume":"36","author":"Gomori","year":"1998","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0095","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, v.1.2148. Page on Carcinomatous\/Lymphomatous Meningitis. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/cns.pdf [accessed April 17, 2014]."},{"key":"10.1016\/j.jocn.2014.10.022_b0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0105","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-013-1083-9","article-title":"The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer","volume":"112","author":"Sperduto","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0115","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1200\/JCO.2009.25.3518","article-title":"Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer","volume":"28","author":"Grewal","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/CAD.0000000000000010","article-title":"Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series","volume":"24","author":"Le Rhun","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jocn.2014.10.022_b0125","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.4103\/0973-1482.122518","article-title":"Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple negative breast cancer","volume":"9","author":"Wu","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jocn.2014.10.022_b0130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdu090","article-title":"Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast cancer therapy","volume":"25","author":"Bane","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/cns.13.66","article-title":"Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches","volume":"3","author":"Lukas","year":"2014","journal-title":"CNS Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3816\/CBC.2003.n.016","article-title":"Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival","volume":"4","author":"Lower","year":"2003","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0145","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who received trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6601970","article-title":"Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer","volume":"91","author":"Clayton","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/14750708.1.1.101","article-title":"Chemotherapy in brain metastases of lung and breast cancer","volume":"1","author":"Tosoni","year":"2004","journal-title":"Therapy"},{"key":"10.1016\/j.jocn.2014.10.022_b0160","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1200\/JCO.2000.18.11.2349","article-title":"Trastuzumab in CSF","volume":"18","author":"Pestalozzi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0165","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djt276","article-title":"Selective permeabilization of the blood\u2013brain barrier at sites of metastasis","volume":"105","author":"Connell","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jocn.2014.10.022_b0170","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","article-title":"Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy","volume":"82","author":"Bokstein","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0175","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2001.19.13.3297","article-title":"Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab","volume":"19","author":"Baculi","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0180","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11095-011-0601-8","article-title":"Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer","volume":"29","author":"Taskar","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.jocn.2014.10.022_b0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-007-9409-0","article-title":"Capecitabine therapy of central nervous system metastases from breast cancer","volume":"85","author":"Ekenel","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0190","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-08-1080","article-title":"Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer","volume":"15","author":"Lin","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocn.2014.10.022_b0195","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11060-011-0629-y","article-title":"Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases","volume":"105","author":"Lin","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0200","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.1991.147","article-title":"Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients","volume":"63","author":"Lien","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/WNL.55.1.117","article-title":"Response of leptomeningeal metastases from breast cancer to hormonal therapy","volume":"55","author":"Boogerd","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.10.022_b0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000327699","article-title":"Delayed but complete response following oral temozolomide treatment in melanoma leptomeningeal carcinomatosis","volume":"4","author":"Hottinger","year":"2011","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1015018808804","article-title":"Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer","volume":"56","author":"Kosmas","year":"2002","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0220","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1200\/jco.2004.22.14_suppl.764","article-title":"Treatment of leptomeningeal carcinomatosis from breast cancer with systemically administered chemotherapy","volume":"22","author":"Trey","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0225","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocn.2014.10.022_b0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10072-009-0044-8","article-title":"Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report","volume":"30","author":"Gaviani","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2014.10.022_b0235","first-page":"3057","article-title":"Intrathecal chemotherapy in carcinomatous meningitis from breast cancer","volume":"22","author":"Orlando","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jocn.2014.10.022_b0240","first-page":"iii1","article-title":"Leptomeningeal metastases in metastatic breast cancer. Safety and tolerability of combined treatment modality including intrathecal therapy, systemic chemotherapy and radiotherapy","volume":"14","author":"Chmielowska","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/0284186X.2012.689857","article-title":"Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases","volume":"52","author":"Martens","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1524-4741.2012.01228.x","article-title":"Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer","volume":"18","author":"Lara-Medina","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.jocn.2014.10.022_b0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.surneu.2004.06.011","article-title":"Intrathecal chemotherapy for patients with meningeal carcinomatosis","volume":"62","author":"Yoshida","year":"2005","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jocn.2014.10.022_b0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02967482","article-title":"Meningeal carcinomatosis in patients with breast cancer: report of 8 patients","volume":"8","author":"Yu","year":"2001","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","article-title":"Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine","volume":"84","author":"Jaeckle","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0270","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jocn.2013.09.018","article-title":"Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin","volume":"21","author":"Salgia","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2014.10.022_b0275","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10549-011-1417-2","article-title":"Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab","volume":"127","author":"Oliveira","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jocn.2014.10.022_b0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.breast.2011.05.007","article-title":"Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis","volume":"20","author":"Mego","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jocn.2014.10.022_b0285","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/annonc\/mdp019","article-title":"Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer","volume":"20","author":"Ferrario","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0290","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/annonc\/mdn654","article-title":"High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer","volume":"19","author":"Mir","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0295","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Euro J Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0300","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/neuonc\/nou089","article-title":"Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials","volume":"16","author":"Chamberlain","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2014.10.022_b0305","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","article-title":"Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis","volume":"116","author":"Glantz","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2014.10.022_b0310","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.33.12.1565","article-title":"Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma","volume":"33","author":"Ongerboer de Visser","year":"1983","journal-title":"Neurology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814006730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814006730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T19:50:40Z","timestamp":1566330640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814006730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0967586814006730"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.10.022","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of leptomeningeal carcinomatosis: Current challenges and future opportunities","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}